98 related articles for article (PubMed ID: 27078990)
1. [Combination of Jianpi Liqi Yiliu Formula with Cytokine-induced Killer Cell Treatment for Advanced Hepatocellular Carcinoma].
Long SQ; Zhang XX; Yang XB; Zhou YS; He WF; Liao GY; Ouyang YS; Li QP; Huang JP; Deng H; Pan ZQ; Xiao SJ; Cai JZ; Wu WY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Feb; 36(2):160-5. PubMed ID: 27078990
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of DC-CIK combined with sorafenib in the treatment of advanced hepatocellular carcinoma.
Zhou Z; Qin H; Weng L; Ni Y
J BUON; 2019; 24(2):615-621. PubMed ID: 31128014
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma.
Wang XP; Xu M; Gao HF; Zhao JF; Xu KC
World J Gastroenterol; 2013 May; 19(19):2956-62. PubMed ID: 23704829
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
[TBL] [Abstract][Full Text] [Related]
6. [Dendritic cell-cytokine induced killer cell immunotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: safety and efficacy].
Guo W; Liu L; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):674-8. PubMed ID: 24849434
[TBL] [Abstract][Full Text] [Related]
7. [Subcellular proteomic analysis of Tetrazanbigen on human hepatocellular carcinoma cell line QGY-7701].
Yuan YH; Yang XL; Li W; Zheng XH; Gu R; Yu Y
Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):908-11. PubMed ID: 22525503
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
Li L; Zhao W; Wang M; Hu J; Wang E; Zhao Y; Liu L
BMC Gastroenterol; 2018 Sep; 18(1):138. PubMed ID: 30180810
[TBL] [Abstract][Full Text] [Related]
9. Cytokine-induced killer cell infusion combined with conventional treatments produced better prognosis for hepatocellular carcinoma patients with barcelona clinic liver cancer B or earlier stage: A systematic review and meta-analysis.
Li YC; Zhao L; Wu JP; Qu CX; Song QK; Wang RB
Cytotherapy; 2016 Dec; 18(12):1525-1531. PubMed ID: 27746013
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy and prognostic factors for cryoablation patients with advanced hepatocellular carcinoma].
Chang XJ; Lu YY; Bai WL; Chen Y; An LJ; Zhou L; Wang H; Wu Y; Liu Z; Lou M; Zeng Z; Su SH; Yang YP
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):759-63. PubMed ID: 22409849
[TBL] [Abstract][Full Text] [Related]
11. A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China.
Sun L; Fahey P; Zhu X; Ng W; Chen ZP; Qiu Y; Lai H; Lin J; Lin L
Integr Cancer Ther; 2018 Sep; 17(3):902-911. PubMed ID: 29775121
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis.
Yu R; Yang B; Chi X; Cai L; Liu C; Yang L; Wang X; He P; Lu X
Drug Des Devel Ther; 2017; 11():851-864. PubMed ID: 28360510
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
Huang ZM; Li W; Li S; Gao F; Zhou QM; Wu FM; He N; Pan CC; Xia JC; Wu PH; Zhao M
J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib.
Chen D; Zhao P; Li SQ; Xiao WK; Yin XY; Peng BG; Liang LJ
Eur J Surg Oncol; 2013 Sep; 39(9):974-80. PubMed ID: 23845703
[TBL] [Abstract][Full Text] [Related]
15. [Value of CIK in the treatment of TACE combined with RFA for HCC in long-term survival and prognostic analysis].
Wang JP; Li W; Huang ZL; Wu PH; Li XS; Wei YD; Zhou QM; Pan CC; Xia JC; Zhao M
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3062-6. PubMed ID: 23328379
[TBL] [Abstract][Full Text] [Related]
16. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).
Gu Y; Lv H; Zhao J; Li Q; Mu G; Li J; Wuyang J; Lou G; Wang R; Zhang Y; Huang X
Int Immunopharmacol; 2017 Sep; 50():263-269. PubMed ID: 28711032
[TBL] [Abstract][Full Text] [Related]
17. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis.
He G; Zheng C; Huo H; Zhang H; Zhu Z; Li J; Zhang H
Int Immunopharmacol; 2016 Nov; 40():436-442. PubMed ID: 27716591
[TBL] [Abstract][Full Text] [Related]
18. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review.
Cai XR; Li X; Lin JX; Wang TT; Dong M; Chen ZH; Jia CC; Hong YF; Lin Q; Wu XY
Oncotarget; 2017 May; 8(19):31318-31328. PubMed ID: 28412743
[TBL] [Abstract][Full Text] [Related]
19. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
[TBL] [Abstract][Full Text] [Related]
20. [Clinical observation of transcatheter arterial chemoembolization plus sorafenib in the treatment of advanced hepatocellular carcinoma with different types of portal vein tumor thrombosis].
Chen JW; Pang PF; Meng XC; Zhou B; Huang WS; Guo YJ; Zhu KS; Shan H
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(9):663-7. PubMed ID: 23751743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
